CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT05745389
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.

Key Dates

Start date
Oct 25, 2022
Status verified
Jan 2026
Primary completion
Dec 31, 2099
Completion
Dec 31, 2099

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Alopecia Areata
    Pts presenting to enrolling sites across the US are invited to enroll if eligible

Primary Outcome Measure

Alopecia epidemiology, presentation, natural history, management, and outcomes [ Time Frame: A minimum of 10 years from last patient enrolled ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451
Jeffrey Greenberg

Find similar trials in Waltham, MA

Related Studies